Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00455962Phase 2Completed
Phase 2 trial of estradiol and progesterone (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: LH Peak in Response to Estrogen Positive Feedback at 5 days. Started Jan 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00455962.